Pricing Log in Create free account

Iterum Therapeutics PLC (ITRMF) vs Moolec Science SA (MLEC)

Iterum Therapeutics PLC and Moolec Science SA are both Biotechnology companies. Iterum Therapeutics PLC is the larger, with a market value of $1.6M against $1.4M — 1.2× the size. Moolec Science SA has the higher net margin (−7.18% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 14 metrics below, Moolec Science SA leads on 9 and Iterum Therapeutics PLC on 5.

Valuation

Metric ITRMF MLEC Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.00 9.71
P/B n/m 0.03 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA n/m 1.76 0.64
EV/Sales 24.37 0.14 9.21
Earnings yield 0.00% (4,665.32%) (33.15%)
Free cash flow yield 0.00% 4,200.26% (25.50%)

Profitability

Metric ITRMF MLEC Biotechnology median
Gross margin (81.85%) 39.67% 65.16%
Operating margin (2,243.48%) 4.09% 0.00%
Net margin (2,930.54%) (7.18%) 0.00%
Free cash flow margin (2,122.61%) 0.00% 0.00%
Return on equity 285.48% 0.00% (56.36%)
Return on assets (111.35%) 0.00% (48.04%)
Return on invested capital (455.51%) 0.00% 0.00%

Growth

Metric ITRMF MLEC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 57.43% (447.53%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ITRMF MLEC Biotechnology median
Debt to equity (2.87) 4.37 0.00
Current ratio 2.13 0.15 4.72
Net debt to EBITDA 0.24 (2.73) 0.96

Dividend

Metric ITRMF MLEC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ITRMF MLEC Biotechnology median
Market cap 1.59m 1.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack